Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
NFL
U.S.
2024 Election
Local
World
Science
Technology
AI
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
cidrap.umn
6h
Studies show more promising results for RSV drug nirsevimab
The first study, published yesterday in Clinical Infectious Diseases, includes results of a phase 3 clinical trial (MELODY), ...
psychiatryadvisor.com
13h
Studies Examine Cost-Effectiveness of Maternal RSV Vaccination, Nirsevimab in Infants
Seasonal maternal respiratory syncytial virus (RSV) vaccination and nirsevimab for infants demonstrate cost-effectiveness.
Medscape
17h
Nirsevimab Reduces Risk for Severe RSV Among American Indian and Alaskan Native Children
Use of nirsevimab was associated with an approximately 80% reduction in illness due to respiratory syncytial virus (RSV) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Tsunami warnings lifted
Several prisons to be closed
Images of suspect released
Set to return after 20 years
May cut diabetes risk
Recuses himself from case
Nadler to step aside
Billy Long to lead IRS
Winter storm to hit US
Ethics report release blocked
DOJ: Bias against Blacks
Medellin cartel leader freed
Rockefeller tree lights up
Social Security chief pick
Raw milk recall expands
Recalls over 205,000 SUVs
Syrian rebels capture Hama
Satellites to create eclipses
US trade deficit shrinks
Delays oil output hike
Prenatal test spots cancer?
Airlines to pay for delays?
$10B AI data center in LA
Weekly jobless claims rise
Tops $100K for the first time
Taiwan's pres visits Guam
SpaceX sets record
Meet with lawmakers
New AI tools for employees
Joins X Games as CEO
Airbus layoffs
Jury deliberations continue
Related topics
Alaska
Centers for Disease Control and Prevention
Human respiratory syncytial virus
Feedback